Revitalizing Cancer Treatment: Exploring the Role of Drug Repurposing.

Autor: Malla R; Cancer Biology Laboratory, Department of Biochemistry and Bioinformatics, GITAM School of Science, GITAM (Deemed to be University), Visakhapatnam 530045, Andhra Pradesh, India., Viswanathan S; Department of Biochemistry, ACS Medical College and Hospital, Chennai 600007, Tamil Nadu, India., Makena S; Maharajah's Institute of Medical Sciences and Hospital, Vizianagaram 535217, Andhra Pradesh, India., Kapoor S; Department of Genetics, University of Alabama, Birmingham, AL 35233, USA., Verma D; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA., Raju AA; Medicover Hospitals, Visakhapatnam 530022, Andhra Pradesh, India., Dunna M; Center for Biotechnology, Jawaharlal Nehru Technological University, Hyderabad 500085, Telangana, India., Muniraj N; Center for Cancer and Immunology Research, Children's National Hospital, 111, Michigan Ave NW, Washington, DC 20010, USA.

Publikováno v: Cancers [Cancers (Basel)] 2024 Apr 11; Vol. 16 (8). Date of Electronic Publication: 2024 Apr 11.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Photothermal Prussian blue nanoparticles generate potent multi-targeted tumor-specific T cells as an adoptive cell therapy.

Autor: Sweeney EE; Department of Biochemistry & Molecular Medicine, School of Medicine and Health Sciences George Washington University Washington District of Columbia USA.; Center for Cancer and Immunology Research Children's National Hospital Washington District of Columbia USA., Sekhri P; Center for Cancer and Immunology Research Children's National Hospital Washington District of Columbia USA.; The Integrated Biomedical Sciences Program, School of Medicine and Health Sciences George Washington University Washington District of Columbia USA., Muniraj N; The Integrated Biomedical Sciences Program, School of Medicine and Health Sciences George Washington University Washington District of Columbia USA., Chen J; Center for Cancer and Immunology Research Children's National Hospital Washington District of Columbia USA., Feng S; Center for Cancer and Immunology Research Children's National Hospital Washington District of Columbia USA.; George Washington Cancer Center, School of Medicine and Health Sciences George Washington University Washington District of Columbia USA., Terao J; The Integrated Biomedical Sciences Program, School of Medicine and Health Sciences George Washington University Washington District of Columbia USA., Chin SJ; Center for Cancer and Immunology Research Children's National Hospital Washington District of Columbia USA.; George Washington Cancer Center, School of Medicine and Health Sciences George Washington University Washington District of Columbia USA., Schmidt DE; Center for Cancer and Immunology Research Children's National Hospital Washington District of Columbia USA., Bollard CM; Center for Cancer and Immunology Research Children's National Hospital Washington District of Columbia USA.; The Integrated Biomedical Sciences Program, School of Medicine and Health Sciences George Washington University Washington District of Columbia USA., Cruz CRY; Center for Cancer and Immunology Research Children's National Hospital Washington District of Columbia USA.; The Integrated Biomedical Sciences Program, School of Medicine and Health Sciences George Washington University Washington District of Columbia USA., Fernandes R; Center for Cancer and Immunology Research Children's National Hospital Washington District of Columbia USA.; George Washington Cancer Center, School of Medicine and Health Sciences George Washington University Washington District of Columbia USA.; Department of Medicine, School of Medicine and Health Sciences George Washington University Washington District of Columbia USA.

Publikováno v: Bioengineering & translational medicine [Bioeng Transl Med] 2023 Dec 22; Vol. 9 (3), pp. e10639. Date of Electronic Publication: 2023 Dec 22 (Print Publication: 2024).

OPTIMIZING THE GENERATION OF ANTIGEN-SPECIFIC T CELLS FOR THE TREATMENT OF HIGH-RISK MALIGNANCIES

Autor: Murphy, S., Couto, S., Paul, G., Chaudhry, K., Muniraj, N., Lazarski, C., Cruz, C., Bollard, C., Hont, A.

Publikováno v: In Cytotherapy June 2024 26(6) Supplement:S184-S184

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.